- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06579781
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
Rigorous Evaluation of Morehouse School of Medicine's Parent Toolkit 2.0 Intervention (Morehouse Family Health Study)
Study Overview
Status
Conditions
Detailed Description
Child Trends, in partnership with the Morehouse School of Medicine (MSM), will implement Parent Toolkit 2.0. The Georgia Campaign for Adolescent Power & Potential developed the Parent Toolkit intervention and Morehouse School of Medicine's (MSM) Health Promotion Research Center tested and adapted it through an OPA Innovation Network grant.
Child Trends plans to conduct an individual randomized controlled trial (RCT) to evaluate the effectiveness of Parent Toolkit 2.0 in delaying sexual initiation and increasing contraceptive use among youth who engage in sexual activity. Youth outcomes are expected to improve as a result of the expansion of parental knowledge and improvement of parent-teen communication about adolescent health, sexual health, and relationships. Associated outcomes will be measured through two surveys, one of which will be distributed immediately after the intervention ends while the other will be administered nine months after the end of the intervention.
The intended population is youth ages 12-15 living in rural and micropolitan areas in central, north, and southeast Georgia, and their parents or caregivers. A "caregiver" in this context is defined as someone who lives with the child at least 50 percent of the time and who is one of the main people responsible for the child. The parents or caregivers will be the program participants since they are the intended recipients of all intervention-related resources such as the toolkit, videos, and group-based virtual sessions. By contrast, the youth enrolled in the study will not directly engage in the programming.
As a part of this study, treatment group parent/caregiver participants will be asked to:
- Review a self-paced parent guide and four videos modeling parent-teen communication on Canvas
- Attend two 1-hour group sessions with other parents
- Complete baseline and post-intervention surveys
- Participate in an optional focus group discussion
Control group parent/caregiver participants will be asked to:
- Review a self-paced parent guide on Canvas
- Complete baseline and post-intervention surveys
- Participate in an optional focus group discussion
Treatment and control group youth participants will be asked to:
- Complete baseline, post-intervention, and nine-month follow-up surveys
- Participate in an optional focus group discussion
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Asari Offiong, PhD
- Phone Number: (240) 223-9306
- Email: aoffiong@childtrends.org
Study Contact Backup
- Name: Elizabeth Cook, MSPH
- Phone Number: (240) 223-9323
- Email: ecook@childtrends.org
Study Locations
-
-
Georgia
-
Cairo, Georgia, United States, 39827
- Recruiting
- Community Outreach
-
Contact:
- Tressa Tucker, PhD
- Phone Number: (310) 625-1913
- Email: tressatuckerconsulting@comcast.net
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria for Adult Participants:
- 25 to 70 years old
- Lives in an eligible zip code in Georgia
- Parent or caregiver of 12- to 15-year-old child who wants to participate in this study with them
- Lives with child at least 50% of the time
Exclusion Criteria for Adult Participants:
- Lives in a home with a child who is already enrolled in this study
- Raises child with an adult who is already enrolled in this study
Inclusion Criteria for Child Participants:
- 12-15 years old
- Lives with a parent or caregiver who wants to participate in this study with them
- Able to complete surveys on own or with help of support person
Exclusion Criteria for Child Participants:
- Does not have their own email address or phone number
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Condition
Adult participants in the control condition will receive access to an online general health guide for parents that was adapted for this study from a pre-existing health guide.
|
General Health Guide provides information to parents on how to promote health in their families.
|
|
Experimental: Treatment Condition
Adult participants in the treatment condition will receive access to the Parent Toolkit 2.0 intervention, which includes an online interactive guide, four videos modeling parent-teen communication around sex and contraception, and two group-based, virtual sessions with other parents and caregivers.
|
Parent Toolkit 2.0 is designed to equip parents and caregivers with skills to talk to their teens about sex and contraception and ultimately influence their teens' decision-making and behaviors around sex.
The Georgia Campaign for Adolescent Power & Potential (GCAPP) developed the Parent Toolkit intervention.
Morehouse School of Medicine's (MSM) Health Promotion Research Center tested and adapted it through an OPA Innovation Network grant, creating Parent Toolkit 2.0.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
No recent penile-vaginal or oral sex
Time Frame: 9 months after end of program
|
Yes = Has not had penile-vaginal or oral sex in past 3 months; No = Has had penile-vaginal or oral sex in past three months.
|
9 months after end of program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Protected penile-vaginal sex or no penile-vaginal sex
Time Frame: 9 months after end of program
|
Yes = Always used pill, shot, patch, ring, IUD, implant, or condom during penile-vaginal sex OR did not have penile-vaginal sex; No = Had penile-vaginal sex without using pill, shot, patch, ring, IUD, implant, or condom every time
|
9 months after end of program
|
|
Parent-child relationship closeness
Time Frame: Immediately after end of program and 9 months after end of program
|
Score of parent-child relationship, including frequency of having fun doing something with parent, having a good conversation with parent about something that matters to the youth, going to parent when the youth was feeling unhappy or needing help, resolving conflicts together with parent, and comfort talking with parent about important topics.
Scores will range from 0 to 6, with a higher score indicating a better outcome.
|
Immediately after end of program and 9 months after end of program
|
|
Self-efficacy to avoid sex and to use contraceptives
Time Frame: Immediately after end of program and 9 months after end of program
|
Score of confidence in being able to not have penis-in-vagina sex if the youth does not want to and to use birth control every time youth has penile-vaginal sex.
Scores will range from 0 to 6, with higher scores indicating more self-efficacy.
|
Immediately after end of program and 9 months after end of program
|
|
Emotional wellbeing
Time Frame: Immediately after end of program and 9 months after end of program
|
Score of mental health during past week, including feeling depressed or very sad, fearful, bothered by things that do not usually bother youth, trouble keeping mind on what youth is doing, that everything youth did used up a lot of their energy, hopeful about the future, hard to go to sleep or stay asleep, happy, lonely, could not get going.
Scores will range from 0 to 30, with higher scores indicating better mental health.
|
Immediately after end of program and 9 months after end of program
|
|
Intention to avoid sex and to use contraceptives
Time Frame: Immediately after end of program and 9 months after end of program
|
Score of intentions to not have penis-in-vagina sex in the next year and to use (or support their partner in using) birth control during penile-vaginal sex in next year.
Scores will range from 0 to 3, with higher scores indicating stronger intentions.
|
Immediately after end of program and 9 months after end of program
|
|
No recent penile-vaginal sex
Time Frame: 9 months after end of program
|
Yes = Has not had consensual penile-vaginal sex in past 3 months; No = Has had consensual penile-vaginal sex in past 3 months.
|
9 months after end of program
|
|
Never had penile-vaginal sex
Time Frame: 9 months after end of program
|
Yes = Has never had consensual penile-vaginal sex; No = Has had consensual penile-vaginal sex.
|
9 months after end of program
|
|
Never had penile-vaginal or oral sex
Time Frame: 9 months after end of program
|
Yes = Has never had consensual penile-vaginal or oral sex; No = Has had consensual penile-vaginal or oral sex.
|
9 months after end of program
|
|
Parent-child communication
Time Frame: Immediately after end of program and 9 months after end of program
|
Score of talking with parent/caregiver about important topics, such as online safety, love languages, healthy relationships, peer pressure and bullying, puberty, sexual activity, reproduction, birth control, condoms, STIs, and going to the doctor for sexual health care.
Scores will range from 0 to 16, with a higher score indicating a better outcome.
|
Immediately after end of program and 9 months after end of program
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jennifer Manlove, PhD, Child Trends
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Child Trends
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexually Transmitted Diseases
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSTI | Sexually Transmitted Disease (STD) | Sexually Transmitted Infection (STI)United States
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...Terminated
-
University of ChicagoCompletedSexually Transmitted InfectionUnited States
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedSexually Transmitted InfectionFrance
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); MRC/UVRI and LSHTM Uganda Research... and other collaboratorsCompletedSexually Transmitted InfectionUganda
-
Sagami Rubber Industries Co., Ltd.Essential Access HealthCompletedContraception | Prevention of Sexually Transmitted InfectionsUnited States
-
NYU Langone HealthCompletedHiv | Sexually Transmitted InfectionUnited States
-
Centre Hospitalier Régional d'OrléansCompleted
Clinical Trials on Morehouse Family Health Study's General Health Guide
-
Kovacs FoundationSpanish Back Pain Research Network (REIDE)Completed
-
Kovacs FoundationConseill Insular de Ibiza y Formentera; Mallorca Institute of Social AffairsWithdrawn
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular DiseasesUnited States
-
American Heart AssociationIntel CorporationCompleted
-
Rhode Island HospitalCompleted
-
University of California, San DiegoCompleted
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH); Emory University; University of Mississippi... and other collaboratorsCompletedMedication Adherence | Retention in CareUnited States
-
Mayo ClinicGE HealthcareCompleted
-
RANDMakerere UniversityNot yet recruitingFamily Planning
-
Aetna, Inc.Intel CorporationCompleted